Skip to Content
Merck
  • CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.

CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.

Cancer cell (2011-11-19)
Jiaying Tan, Morgan Jones, Haruhiko Koseki, Manabu Nakayama, Andrew G Muntean, Ivan Maillard, Jay L Hess
ABSTRACT

Chromosomal translocations involving the mixed lineage leukemia (MLL) gene lead to the development of acute leukemias. Constitutive HOX gene activation by MLL fusion proteins is required for MLL-mediated leukemogenesis; however, the underlying mechanisms remain elusive. Here, we show that chromobox homolog 8 (CBX8), a Polycomb Group protein that interacts with MLL-AF9 and TIP60, is required for MLL-AF9-induced transcriptional activation and leukemogenesis. Conversely, both CBX8 ablation and specific disruption of the CBX8 interaction by point mutations in MLL-AF9 abrogate HOX gene upregulation and abolish MLL-AF9 leukemic transformation. Surprisingly, Cbx8-deficient mice are viable and display no apparent hematopoietic defects. Together, our findings demonstrate that CBX8 plays an essential role in MLL-AF9 transcriptional regulation and leukemogenesis.